Literature DB >> 10340977

Ocular signs and symptoms and vitamin A status in patients with cystic fibrosis treated with daily vitamin A supplements.

E A Ansari1, K Sahni, C Etherington, A Morton, S P Conway, E Moya, J M Littlewood.   

Abstract

BACKGROUND/AIMS: Patients with cystic fibrosis (CF) may have low plasma vitamin A levels from malabsorption, zinc deficiency, liver disease, or poor compliance with prescribed supplements. In view of the increasing number of adults with CF, many of whom drive cars, it is important to assess vitamin A status. In our centre an attempt has been made to achieve normal levels of fat soluble vitamins by annual estimation of plasma levels and appropriate oral supplementation. This study aimed to determine if this approach prevents vitamin A deficiency and the consequent problems with dark adaptation.
METHODS: The study was conducted at the regional adult and paediatric cystic fibrosis unit and the patients were recruited from there. Dark adaptation studies were conducted at the department of ophthalmology, St James's University Hospital. All patients are regularly seen in the outpatient department by a CF specialist dietitian and have a comprehensive annual dietary assessment. 28 patients had the following investigations: serum retinol, plasma zinc, serum retinol binding protein, liver function tests, dark adaptation, contrast sensitivity, and anterior ocular surface status. 25 age and sex matched controls without CF or ocular pathology were also recruited for the dark adaptation study.
RESULTS: None of the patients had vitamin A deficiency, the median value of serum retinol being 48 microg/dl, range 31-80 microg/dl (normal range 30-80 microg/dl). Dark adaptation was normal in all cases compared with the control group where the mean value was 3.4 log units of threshold luminance (95% confidence interval 2.4-4.0). None of the test group had a value of threshold luminance 2 SD above the mean value for the control group. Eight patients had reduced contrast sensitivity. The median value for serum zinc was 14.2 micromol/ l, range 13-81 micromol/l (normal range 8-23 micromol/l) and the median value for retinol binding protein was 36 mg/l, range 13-81 mg/l (normal range 35-58 mg/l). There was no correlation between dark adaptation and serum retinol, zinc, or retinol binding protein. Two patients had clinical evidence of dry eye.
CONCLUSION: Regular estimates of plasma vitamin A together with appropriate supplementation and expert dietetic review can maintain normal dark adaptation in patients with cystic fibrosis. The occurrence of reduced contrast sensitivity function is well documented but remains an unexplained phenomenon and deserves further study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340977      PMCID: PMC1723080          DOI: 10.1136/bjo.83.6.688

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  14 in total

Review 1.  Vitamin A deficiency today: conjunctival xerosis in cystic fibrosis.

Authors:  A Sommer
Journal:  J R Soc Med       Date:  1989-01       Impact factor: 5.344

2.  The Copenhagen criteria for Sjögren's syndrome.

Authors:  R Manthorpe; P Oxholm; J U Prause; M Schiødt
Journal:  Scand J Rheumatol Suppl       Date:  1986

3.  Essential element nutritional status in cystic fibrosis.

Authors:  J Kelleher; H F Goode; H P Field; B E Walker; M G Miller; J M Littlewood
Journal:  Hum Nutr Appl Nutr       Date:  1986-04

4.  Ocular findings in cystic fibrosis.

Authors:  R F Spaide; G Diamond; R A D'Amico; P F Gaerlan; D S Bisberg
Journal:  Am J Ophthalmol       Date:  1987-02-15       Impact factor: 5.258

5.  Vitamin A deficiency and xerophthalmia in the United Kingdom.

Authors:  N J Watson; C H Hutchinson; H R Atta
Journal:  BMJ       Date:  1995-04-22

6.  The 20/20 eye in multiple sclerosis.

Authors:  M J Kupersmith; J I Nelson; W H Seiple; R E Carr; P A Weiss
Journal:  Neurology       Date:  1983-08       Impact factor: 9.910

7.  Nyctalopia and conjunctival xerosis indicating vitamin A deficiency in cystic fibrosis.

Authors:  M A Neugebauer; S A Vernon; G Brimlow; J C Tyrrell; E J Hiller; C Marenah
Journal:  Eye (Lond)       Date:  1989       Impact factor: 3.775

8.  Loss of contrast sensitivity in cystic fibrosis.

Authors:  L E Leguire; K S Pappa; M L Kachmer; G L Rogers; D L Bremer
Journal:  Am J Ophthalmol       Date:  1991-04-15       Impact factor: 5.258

9.  Zinc deficiency and photoreceptor dysfunction in chronic liver disease.

Authors:  P W Keeling; J O'Day; W Ruse; R P Thompson
Journal:  Clin Sci (Lond)       Date:  1982-01       Impact factor: 6.124

10.  Ocular findings in cystic fibrosis patients receiving vitamin A supplementation.

Authors:  J C Morkeberg; C Edmund; J U Prause; S Lanng; C Koch; K F Michaelsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-11       Impact factor: 3.117

View more
  7 in total

1.  Why bother to take vitamins?

Authors:  Alison Morton
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

2.  Retinol binding protein status in relation to ocular surface changes in patients with cystic fibrosis treated with daily vitamin A supplements.

Authors:  Malgorzata Mrugacz; Jolanta Tobolczyk; Alina Minarowska
Journal:  Eur J Pediatr       Date:  2004-11-20       Impact factor: 3.183

Review 3.  Aquaporins and CFTR in ocular epithelial fluid transport.

Authors:  M H Levin; A S Verkman
Journal:  J Membr Biol       Date:  2006-07-25       Impact factor: 1.843

4.  Lutein, zeaxanthin, macular pigment, and visual function in adult cystic fibrosis patients.

Authors:  Christine Schupp; Estibaliz Olano-Martin; Christina Gerth; Brian M Morrissey; Carroll E Cross; John S Werner
Journal:  Am J Clin Nutr       Date:  2004-06       Impact factor: 7.045

5.  Small-molecule CFTR activators increase tear secretion and prevent experimental dry eye disease.

Authors:  Alyssa M Flores; Scott D Casey; Christian M Felix; Puay W Phuan; A S Verkman; Marc H Levin
Journal:  FASEB J       Date:  2016-02-03       Impact factor: 5.191

6.  ERGs in children with pancreatic enzyme insufficient and pancreatic enzyme sufficient cystic fibrosis.

Authors:  Andrew Whatham; Catherine Suttle; Caron Blumenthal; Jane Allen; Kevin Gaskin
Journal:  Doc Ophthalmol       Date:  2009-03-03       Impact factor: 2.379

7.  CFTR-mediated Cl(-) transport in the acinar and duct cells of rabbit lacrimal gland.

Authors:  Michael Lu; Chuanqing Ding
Journal:  Curr Eye Res       Date:  2012-05-11       Impact factor: 2.424

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.